Traitement of tobacco addiction: Brief and intensive clinical intervention;Traitement de dependance tabagique: Conseil minimal et prise en charge organisee

Tunisie Medicale

Volumn 82, Issue 1, 2004, Pages 1-11

  Fakhfakh, Radhouane ^a   Hsairi, Mohamed ^a   Gharbi, Leila ^a   Aouina, Hichem ^a   Bouacha, Hend ^a   Achour, Noureddine ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Behavioral and cognitive therapy; Bupropion; Nicotine replacement therapy; Smoking cessation; Tobacco Dependence

Indexed keywords

AMFEBUTAMONE; NICOTINE; DOPAMINE UPTAKE INHIBITOR; GANGLION STIMULATING AGENT;

BEHAVIOR; COGNITIVE THERAPY; HEALTH PRACTITIONER; HUMAN; MEDICAL EDUCATION; MEDICAL LITERATURE; MEDICAL PROFESSION; PHYSICIAN; REVIEW; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; ANXIETY; DEPRESSION; HEALTH CARE PERSONNEL; INTERVENTION STUDY; METHODOLOGY;

ANXIETY; BUPROPION; COGNITIVE THERAPY; DEPRESSION; DOPAMINE UPTAKE INHIBITORS; GANGLIONIC STIMULANTS; HEALTH PERSONNEL; HUMANS; INTERVENTION STUDIES; NICOTINE; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 2042474735     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. World Health Organization. World Health Report 1999. Making a Difference. Geneva. World Health Organization, 1999.
2. US Departement of Health and Human Services. The Health benefice of smoking cessation. A Report of Surgeon General. Rockville MD; Centers for Disease Controle, 1990 (DHHS Publications. CDC 90-8416).
3. Doll R., Peto R., Wheatly K., Gray R., Sutherland I., Mortality in relation to smoking: 40 year's observations on male British doctors. Br Med J 1994;309(6954):901-11.
4. Fakhfakh R, Ben Romdhane H, Hsairi M, Achour N, Nacef T: Tendances de la consommation tabagique en Tunisie. Revue de santé de la Méditerranée Orientale 2000,6(4):678-686.
5. Fakhfakh R, Hsairi M, Maalej M, Achour N, Nacef T: Tobacco use in Tunisia: behavior and awareness. Bulletin of the World Health Organization 2002,80:350-356.
6. Fakhfakh R, Ben Romdhane H, Hsairi M, Achour N, Nacef T: Mortalité attribuable au tabac en Tunisie 1997. La Tunisie Médicale 2001,79:408-12.
7. Fakhfakh R, Achour N. Stratégie nationale de lutte contre le tabagisme. Institut National de Santé Publique, 1999.
8. USDHHS (Us department of Health and Human Services). The health benefits of smoking cessation. Report of Surgeon General. DHHS Publication 90-8416. US Departement of Health Promotion (Center of Disease Control and Prevention), Office on smoking and Health, Rockville, 1990.
9. Jarvis M.J. Patterns and predictors of smoking Cessation in the General Population in Bolliger CT, Fogerström KO(eds)/The tobacco epidemic. Prog Resp. Res. Basel, Karger, 1997,28:151-164.
10. Fokhfakh R, Hsairi M, Ben Romdhane H, Achour N, Ben Ammar R et all: Le tabagisme des étudiants en médecine: Tendance des comportements et des attitudes. Cohiers Santé 1996;6:37-42.
11. Cohen SJ, Stookey GK, Katz BP, Drook CA, Smith DM. Encouraging primary care physcians to help smokers quit: a randomized, controlled trial. Ann. Intern. Med 1989;110(8):648-52.
12. Ockene JK, Kristeller J, Goldberg R, Amick TL, Pekow PS, Hsmer D, Quirk M, Kolon K. Increasing the efficacy of physicia,-delivred smoking interventions: a randomized clinical trial. J. Gen. Intern. Med. 1991;6(1):1-8.
13. Glyn TJ. Relative effectiveness of physician-initiated smoking cessation programs. Cancer bulletin 1988.
14. Schwartz JL. Review and evaluation of smoking cessation methods. The United States and Canada 1978-1985. Bethesda (MD). US Departement of Health and Human Services, Public Health Service, National Instituts of Health, Natioan Cancer Institute. Division of Cancer Prevention and Control, 1987. NIH Publicatin n°87-2940.
15. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER and all. Smoking Cessation. Treating tobacco use and Dependance. Clinical Practice Guideline. Rockeville (MD): US Departement of Heath and Human Services, Public Health Service, 2000.
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström KO. The Fagerstöm test for Nicotine dependence: a revision of the Fageström tolerance questionnaire. Brit J Addict, 1991,86:1119-227.
17. Moyfield M, MC Leod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am. J. Psychiatry, 1974, 131:1121-1123.
18. Zigmond, A.S., Snoith R.P., The Hospital Anxiety and Depression Scale, Acta Psychiatr. Scand., 1983;67(6):361-70.
19. Collet L. et Cochraux J. Inventaire abrégé de la dépression de Beck (13 items). Etude de la validité. Encéphale 1986;12(2):77-9.
20. Sheehan DV, Lecrubier Y, Sheehan KH et oll: The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and Validation of Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-23.
21. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med, 1988;319:1318-30.
22. Benowitz NL, Gourlay SG: Cardiovascular toxicity of nicotine, implications for nicotine replacement therapy. J Am Coll Cardiol, 1997,29:1422-31.
23. Lagrue G, Dupont P, Fakhfakh R, Moutrait C, Cormier S. Le traitement de substitution nicotinique dix ans oprès. Presse Med 2000;31:291-5
24. Herrera N, Franco R, Herrero L, Portidos A, Roland R, Fagestrom KO. Nicotine gum, 2 and 4 mg, for nicotine dependance. A double-blind placebo-controlled trial within a behavior modification support program. Chest 1995;108(2):447-51.
25. Kornitzer M, Kittel F, Dramaix M, Bourdoux P. A double blind study of 2 mg verus 4 mg nicotine gum in an industrial setting. J Psychosom Res 1987;31(2):171-6.
26. Dale LC, Hurt RD, Offord KP, Lawson GM, Craghan IT and all. High dose nicotine patch therapy. JAMA. 1995;274(17):1353-8.
27. Kozak J, Fageström KO, Säwe U. High-dose treatement with the nicotine patch. Int J Smok Cessation 1995;4:26-8.
28. Fageström KO. Combined use of nicotine replacement products. Health values 1994,18(3):15-20.
29. Stapleton J. Commentary: Progress on nicotine replacement therapy for smokers[comment]. BMJ 1999;318(7179):289.
30. Acher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC. Bupropion: a review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry 1995;56(9):395-401.
31. Ferry LH, Robbins AS, Scoriote AM, Abbey DE, Burchette RJ, et al. Enhancement of smoking cessation using the antidepressant bupropion hypochloride. Circulation 1992;86:671.
32. Ferry LH, Burchette RJ. Efficacy of bupropion for smoking cessation in non depressed smokers. J.Addict Dis 1994;13:249.
33. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA et all: A comparison of sustained release Bupropion and placebo of smoking cessation. N. Engl. J. Med 1997,337:1195-1202.
34. Jorenby DE, Leischow SJ, Nides A et al. A controlled trial of sustained-release bupropion, a nicotine patch or both for smoking cessation. N Engl J Med 1999;340:685-91.
35. Joseph AM, Norman SM, Ferry LH, Prochazko AU, Westmon EC, Stecl BG, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335(24):1792-8.
36. Working Group for the study of transdermal Nicotine in patients with coronary Artery disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994;154:989-95.
37. Glassman A.H. Cigarette Smoking: Implications for psychiatric illness. Am J Psychiatry 1993;150:546-553.
38. Lagrue G, Dupont P. Fakhfakh R. Dépendance tabagique et états anxiodépressifs; L'encéphale 2002(28):374-7.
39. Niaura R, Goldstein M, Depue J, Keuthen N, Kristeller JE, et all. Fluoxetine, symptoms of depression, and smoking cessation. Ann. Beh. Med; 1994,16:S117.
40. Leightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 1997;96(4):1089-96.
41. Fujisawa T, Iizasa T, Saitoh Y, Sekine Y, Motohashi S et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999;17(7):2086-91.
42. Kowahara-M; Ushijima-S; Kamimori-T; Kodama-N; Ogawara-M; and all. Second primary tumors in more than 2 years disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation. Br J Cancer 1998;78(3):409-1.
43. Ministère de la Santé Publique. Santé des adolescents scolarisés: Résultats d'une enquête Nationale. Direction de la médecine scolaire et universitaire 2002 (sous presse).
44. Williamson DF, Madans J, Anda RF, Kleinman JC, Giovino GA et oll. Smoking cessation and severity of weight gain in national cohort. N Engl J Med 1991,324:739-745.
45. Marcus B, Albrecht A, King T, Parisi A. Efficacy of exercise as an aid for smoking cessation in women. Arch Intern Med 1999;159:1229-34.
46. Gross J, Stitzer ML, Maldonado J. Nicotine replacement: effects on post cessation weight gain. J Consult Clin Psychol 1989,57(1):87-92.
47. Doherty K, Militello FS, Kinnunen T, Gavey AJ. Nicotine gum dose and weight gain after smoking cessation. J Consult Clin Psychol 1996; 64(4):799-807.